CDRH Seeks Public Comment: Digital Health Technologies for Detecting Prediabetes and Undiagnosed Type 2 Diabetes

• URL: http://arxiv.org/abs/2312.11226v1
• Date: Mon, 18 Dec 2023 14:20:53 GMT
• Title: CDRH Seeks Public Comment: Digital Health Technologies for Detecting Prediabetes and Undiagnosed Type 2 Diabetes
• Authors: Manuel Cossio
• Abstract summary: FDA asked for public comments on role of digital health technologies (DHTs) in detecting prediabetes and undiagnosed type 2 diabetes. DHTs capture health signals like glucose, diet, symptoms and community insights. Subpopulations that could benefit most from remote screening tools include rural residents, minority groups, high-risk individuals and those with limited healthcare access.
• Score: 0.0
• License: http://creativecommons.org/licenses/by/4.0/
• Abstract: This document provides responses to the FDA's request for public comments (Docket No FDA 2023 N 4853) on the role of digital health technologies (DHTs) in detecting prediabetes and undiagnosed type 2 diabetes. It explores current DHT applications in prevention, detection, treatment and reversal of prediabetes, highlighting AI chatbots, online forums, wearables and mobile apps. The methods employed by DHTs to capture health signals like glucose, diet, symptoms and community insights are outlined. Key subpopulations that could benefit most from remote screening tools include rural residents, minority groups, high-risk individuals and those with limited healthcare access. Capturable high-impact risk factors encompass glycemic variability, cardiovascular parameters, respiratory health, blood biomarkers and patient reported symptoms. An array of non-invasive monitoring tools are discussed, although further research into their accuracy for diverse groups is warranted. Extensive health datasets providing immense opportunities for AI and ML based risk modeling are presented. Promising techniques leveraging EHRs, imaging, wearables and surveys to enhance screening through AI and ML algorithms are showcased. Analysis of social media and streaming data further allows disease prediction across populations. Ongoing innovation focused on inclusivity and accessibility is highlighted as pivotal in unlocking DHTs potential for transforming prediabetes and diabetes prevention and care.

Related papers

• DiabML: AI-assisted diabetes diagnosis method with meta-heuristic-based feature selection [4.788163807490197]
  We propose a hybrid diabetes risk detection method, DiabML, using the BWO algorithm and ML methods. DiabML achieves 86.1% classification accuracy by AdaBoost.
  arXiv  Detail & Related papers  (2024-10-30T16:06:58Z)
• A Survey of Artificial Intelligence in Gait-Based Neurodegenerative Disease Diagnosis [51.07114445705692]
  neurodegenerative diseases (NDs) traditionally require extensive healthcare resources and human effort for medical diagnosis and monitoring. As a crucial disease-related motor symptom, human gait can be exploited to characterize different NDs. The current advances in artificial intelligence (AI) models enable automatic gait analysis for NDs identification and classification.
  arXiv  Detail & Related papers  (2024-05-21T06:44:40Z)
• Physical formula enhanced multi-task learning for pharmacokinetics prediction [54.13787789006417]
  A major challenge for AI-driven drug discovery is the scarcity of high-quality data. We develop a formula enhanced mul-ti-task learning (PEMAL) method that predicts four key parameters of pharmacokinetics simultaneously. Our experiments reveal that PEMAL significantly lowers the data demand, compared to typical Graph Neural Networks.
  arXiv  Detail & Related papers  (2024-04-16T07:42:55Z)
• Artificial Intelligence and Diabetes Mellitus: An Inside Look Through the Retina [7.740438266232459]
  We review the literature for studies on AI applications based on retinal images related to diabetes diagnosis, prognostication, and management. We will describe the findings of holistic AI-assisted diabetes care, including but not limited to DR screening. We will discuss barriers to implementing such systems, including issues concerning ethics, data privacy, equitable access, and explainability.
  arXiv  Detail & Related papers  (2024-02-28T00:31:17Z)
• Diabetes detection using deep learning techniques with oversampling and feature augmentation [0.3749861135832073]
  Diabetes is a chronic pathology which is affecting more and more people over the years. It gives rise to a large number of deaths each year. Many people living with the disease do not realize the seriousness of their health status early enough.
  arXiv  Detail & Related papers  (2024-02-03T15:30:20Z)
• MedDiffusion: Boosting Health Risk Prediction via Diffusion-based Data Augmentation [58.93221876843639]
  This paper introduces a novel, end-to-end diffusion-based risk prediction model, named MedDiffusion. It enhances risk prediction performance by creating synthetic patient data during training to enlarge sample space. It discerns hidden relationships between patient visits using a step-wise attention mechanism, enabling the model to automatically retain the most vital information for generating high-quality data.
  arXiv  Detail & Related papers  (2023-10-04T01:36:30Z)
• HealthEdge: A Machine Learning-Based Smart Healthcare Framework for Prediction of Type 2 Diabetes in an Integrated IoT, Edge, and Cloud Computing System [0.0]
  The alarming increase in diabetes calls for the need to take precautionary measures to avoid/predict the occurrence of diabetes. This paper proposes HealthEdge, a machine learning-based smart healthcare framework for type 2 diabetes prediction in an integrated IoT-edge-cloud computing system.
  arXiv  Detail & Related papers  (2023-01-25T07:57:18Z)
• Secure and Privacy-Preserving Automated Machine Learning Operations into End-to-End Integrated IoT-Edge-Artificial Intelligence-Blockchain Monitoring System for Diabetes Mellitus Prediction [0.5825410941577593]
  This paper proposes an IoT-edge-Artificial Intelligence (AI)-blockchain system for diabetes prediction based on risk factors. The proposed system is underpinned by the blockchain to obtain a cohesive view of the risk factors data from patients across different hospitals. Numerical experiments and comparative analysis were carried out between our proposed system, using the most accurate random forest (RF) model.
  arXiv  Detail & Related papers  (2022-11-13T13:57:14Z)
• An Interpretable Multiple-Instance Approach for the Detection of referable Diabetic Retinopathy from Fundus Images [72.94446225783697]
  We propose a machine learning system for the detection of referable Diabetic Retinopathy in fundus images. By extracting local information from image patches and combining it efficiently through an attention mechanism, our system is able to achieve high classification accuracy. We evaluate our approach on publicly available retinal image datasets, in which it exhibits near state-of-the-art performance.
  arXiv  Detail & Related papers  (2021-03-02T13:14:15Z)
• UNITE: Uncertainty-based Health Risk Prediction Leveraging Multi-sourced Data [81.00385374948125]
  We present UNcertaInTy-based hEalth risk prediction (UNITE) model. UNITE provides accurate disease risk prediction and uncertainty estimation leveraging multi-sourced health data. We evaluate UNITE on real-world disease risk prediction tasks: nonalcoholic fatty liver disease (NASH) and Alzheimer's disease (AD) UNITE achieves up to 0.841 in F1 score for AD detection, up to 0.609 in PR-AUC for NASH detection, and outperforms various state-of-the-art baselines by up to $19%$ over the best baseline.
  arXiv  Detail & Related papers  (2020-10-22T02:28:11Z)
• Short Term Blood Glucose Prediction based on Continuous Glucose Monitoring Data [53.01543207478818]
  This study explores the use of Continuous Glucose Monitoring (CGM) data as input for digital decision support tools. We investigate how Recurrent Neural Networks (RNNs) can be used for Short Term Blood Glucose (STBG) prediction.
  arXiv  Detail & Related papers  (2020-02-06T16:39:44Z)

This list is automatically generated from the titles and abstracts of the papers in this site.

This site does not guarantee the quality of this site (including all information) and is not responsible for any consequences.